Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles
Shenyang Xingqi Pharmaceutical (300573.SZ): Beimeiquanlisu eye drops received drug registration certificate.
Betting on the transition of energy and the AI wave, European copper industry giants accelerate the expansion of their global business footprint.
Zhuhai Rundu Pharmaceutical (002923.SZ) has received the registration certificate for sodium diclofenac sustained-release tablets.
Shenyang Xingqi Pharmaceutical (300573.SZ): Beimeiquanlisu eye drops received drug registration certificate.
Betting on the transition of energy and the AI wave, European copper industry giants accelerate the expansion of their global business footprint.
Zhuhai Rundu Pharmaceutical (002923.SZ) has received the registration certificate for sodium diclofenac sustained-release tablets.
